# A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)

> **NCT00109135** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 300 (actual)

## Conditions studied

- Smoking

## Interventions

- **DRUG:** taranabant

## Key facts

- **NCT ID:** NCT00109135
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2015-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109135, "A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00109135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*